Summary
Summary

1.
Human polymorphonuclear leucocyte elastase and cathepsin G were incubated with preparations of isolated human glomerular base ment membrane at neutral pH and 37°C.
2. The ability of these enzymes to degrade glomerular basement membrane was followed by the release of hydroxyproline. Both proteinases released considerable amounts of hydroxyproline.
3. By using Sephadex G-100 it was shown that the solubilized basement membrane fragments appeared as a single peak and had a molecular weight of over 100 000. These proteins after reduc tion were analysed by sodium dodecyl sulphate-gel electrophoresis to examine their subunit pattern and determine their molecular size.
4. The released basement membrane proteins gave at least four precipitin lines with a rabbit anti-(glomerular basement membrane) antiserum.
5. These results support the concept that poly morphonuclear leucocyte neutral proteinases play an important role in the pathogenesis of glomerulo nephritis.
6. At acid pH values cathepsin B also released hydroxyproline from human glomerular basement membrane but the lysosomal carboxyl proteinase, cathepsin D, had no action.
Introduction
At least two types of immunologically mediated glomerular disease have been discovered by animal studies (Dixon, 1968) . One is induced by deposition within the glomeruli of immunecomplexes formed in the circulation, and the other by anti-(glomerular basement membrane) anti bodies. Damage to the glomerular basement membrane (GBM) in experimental anti-GBM anti bodies disease may occur through fixation of antibody to the basement membrane, which is followed by activation and binding of complement; this causes the chemotactic attraction of poly morphonuclear leucocytes, which in turn selec tively release their lysosomal enzymes which degrade the GBM, so that fragments can be detected in the urine together with neutrophilderived enzymes. It is likely that a similar mechan ism is responsible for the renal damage in acute forms of immune-complex disease, although this is not as well documented.
It is now recognized that both types of immunological injury occur in man, with the immunecomplex type accounting for most cases of human glomerulonephritis (Dixon, 1968) . Some patients with this condition have been shown to have leucocytes in their glomeruli. However, there has been no direct evidence to implicate leucocyte enzymes in the pathogenesis of human renal disease. Sanders, Coles & Davies (1976) have recently demonstrated that patients with rapidly progressive proliferative glomerulonephritis excrete a neutral proteinase together with fragments of GBM in their urine. This enzyme appears to possess many of the properties of polymorphonuclear leucocyte elastase (EC 3.4.2.1). It is therefore important to know whether this elastase can degrade GBM. To answer this question we have studied the effect of incubating highly purified leucocyte elastase with human GBM at neutral pH. We have also investigated another neutral pro teinase found in human polymorphonuclear leucocytes, cathepsin G (EC 3.4.21.20 ) and in addition two lysosomal acid proteinases found in human kidney.
Materials and methods
Human glomerular basement membrane
This was isolated from normal kidneys obtained at autopsy, by the method of Krakhower & Greenspon (1951) as modified by Spiro (1967) . In our isolation procedure p-mercuribenzoate (28 //mol/1) was included in the sodium phosphate (10 mmol/1) buffer/NaCl (150 mmol/1), pH 7-2 (phosphate-buffered saline), to minimize any degradation of basement membrane by endogenous thiol-dependent proteinases. The isolated glomeruli were suspended in isotonic sodium chloride solution, centrifuged at 600 g for 15 min and the supernatant was discarded. This procedure was repeated five times.
Basement membrane was obtained from the glomeruli by ultrasonic disruption. The glomeruli were suspended in 25 ml of NaCl (1 mol/1) in a McCartney bottle immersed in a salt/ice mixture. A MSE Sonicator (model 500) with a stainless-steel probe was tuned to give maximum sonication at setting 10 and used at this setting in 1 min bursts. The suspension was cooled between each burst. The extent of glomerular disruption was followed microscopically. Almost complete disruption was achieved after eight bursts. The sonicated material was washed five times in NaCl (1 mol/1) and finally three times with distilled water. The final prepara tion was suspended in 20 ml of water and freezedried. It was free of DNA and RNA and con tained no proteolytic activity at acid or neutral pH.
Antiserum to human GBM was raised in New Zealand White rabbits. Before use the antiserum was absorbed with normal human serum. Double diffusion was performed in 1% agarose (2 mm well size) in sodium phosphate buffer (50 mmol/1), pH 7-0, at room temperature for 24 h.
Human lysosomal elastase and cathepsin G
These were prepared by the method of Baugh & Travis (1976) modified in that a NaCl gradient to 1 mol/1 was used to elute cathepsin G from the carboxymethylcellulose column. Cathepsins B and D were prepared as described by Barrett (1973) .
The degradation of glomerular basement mem brane by lysosomal proteinase was assayed in mixtures (500 μ\) containing 2 mg of glomerular basement membrane, Tris/HCI buffer (200 mmol/1), pH 7-4, and various amounts of enzyme (see the Results section). The tubes were rotated in a roller rocker and maintained at 37 °C for 18 h. After the incubation period the tubes were centri fuged at room temperature and the supernatant was carefully removed. Samples of this super natant were hydrolysed in HC1 (6 mol/1) for 20 h in sealed glass ampoules before analysis for hydroxyproline. Samples of the supernatant were also examined by sodium dodecyl sulphate (SDS) polyacrylamide-gel electrophoresis. The pellet remaining after the removal of the supernatant was washed once with 500 μ\ of distilled water and centrifuged. The supernatant was discarded and the pellet resuspended in 500 μ\ of distilled water. Portions (350 μΐ) were hydrolysed with HC1 (6 mol/1) as above for hydroxyproline determination. The remainder was used for SDS-polyacrylamidegel electrophoresis. The results were expressed as the amount of hydroxyproline made soluble over the incubation period (i.e. hydroxyproline present in the supernatant divided by hydroxyproline present in the supernatant plus pellet, expressed as a percentage).
Hydroxyproline determinations were carried out as described by Burleigh, Barrett & Lazarus (1974) , except that the incubation at 65 °C was for 15 min.
SDS-polyacrylamide-gel electrophoresis was carried out in 7-5% gels prepared in Tris (0-1 mol/l)-Bicine buffer, pH 8·1. Samples were incu bated at 100°C for 5 min in 1% SDS/Tris (0·1 mol/l)-Bicine buffer (pH 8-l)/2-mercaptoethanol (0-43 mol/1), 20% (2-73 mol/1) glycerol/0· 1% Bromophenol Blue; portions (25-50 ,ug) of the mixture were applied to the gels. Human GBM was solubilized by incubation at 50 °C for 60 h. The gels were stained for protein with 0· 1% Coomassie Brilliant Blue R250 as described by Starkey & Barrett (1976) .
Enzyme assays
Human polymorphonuclear leucocyte neutral proteinase activity. This was measured in leucocytes from the peripheral blood of two healthy donors, obtained by dextran sedimentation and centrifugation on a Hypaque Ficol gradient (Böyum, 1968) . The leucocyte preparation was washed with cold 0-2% NaCl to lyse contaminating erythrocytes and 1·6% NaCl was added to restore isotonicity. The cells were centrifuged again and the above procedure was repeated until no erythrocytes remained. Leucocyte granules were prepared and extracted as described by Baugh & Travis (1976) .
Total neutralproteolytic activity. This was deter mined with azocasein as substrate (Starkey & Barrett, 1976) , except that a temperature of 45°C was used. Under the conditions of the assay Δ/4 366 was linear with time up to 30 min and linear with enzyme concentration of up to 0-35 unit. One unit of activity is defined as the amount of enzyme which would have given AA 3se of 1-0 in 30 min at 45 ° C, if the response were linear to this value.
Elastase and cathepsin activity. Elastase activity was measured against JV-benzyloxycarbonyl-Lalanine 2-naphthyl ester (kindly given by Dr C. G. Knight, Strangeways Research Laboratory, Cam bridge, U.K.) and cathepsin G (chymotrypsin-like enzyme) against iV-benzoyl-DL-phenylalanine 2-naphthyl ester (Starkey & Barrett, 1976) . Activities for elastase and cathepsin G were first calculated in nkat (i.e. activity hydrolysing 1 nmol of substrate/s) and then converted into equivalent azocasein units on the basis of the values for the pure enzymes given by Starkey & Barrett (1976) . Cathepsin B (EC 3.4.22.1) was assayed with a-Nbenzoyl-DL-arginine-2-naphthylamide HC1 (Bar rett, 1976) .
Results
Degradation of human glomerular basement mem brane by leucocyte neutral proteinases
Since collagen is a major structural component of glomerular basement membrane, the release of hydroxyproline was used as a convenient marker of membrane digestion. The effect of leucocyte elastase on human glomerular basement membrane in suspension was investigated over a range of enzyme concentrations. The release of hydroxy proline increased with amount of enzyme (0-5-2-0 units) up to 70% of the available hydroxyproline (Fig. la) . Cathepsin G also caused the release of hydroxyproline but not to the same extent as that achieved with elastase (Fig. la) . In a separate experiment human basement membrane was incu bated with elastase (0-25 unit/mg) and with cathepsin G (0-5 unit/mg of GBM) over a period of 90 h. Under these conditions elastase released 93% of the total hydroxyproline. Efforts to release the remaining hydroxyproline with fresh enzymes were unsuccessful. Under the same conditions cathepsin G released 81% of the available hydroxyproline.
Behaviour of reaction products on gel filtration
An attempt was made to characterize the products made soluble by elastase and cathepsin G by separation on a column of Sephadex G-100. It was found that the elution profiles (Fig. 2) , charac terized by their absorbance at 280 nm and hydroxyproline content, from both experiments were almost identical (described in Table 1 ). The high-molecular-weight component (fraction 1) eluted in the void volume and contained hydroxy proline. A second fraction (fraction 2) containing hydroxyproline eluted before some low-molecularweight proteins. Fraction 1 from both experiments was analysed by SDS-gel electrophoresis. Tubes which contained hydroxyproline were pooled, dialysed against distilled water and freeze-dried. The material was redissolved in distilled water, reduced with 2-mercaptoethanol and then exam ined by SDS-gel electrophoresis. The electro phoresis patterns of fraction 1 were compared with that of whole glomerular basement membrane (Fig.  3) . Comparisons of the gels showed a hetero geneous distribution of proteins with respect to molecular weight. Similar results were obtained with the elastase and cathepsin G digestion products. Proteins with molecular weights of less than 100 000 were noted.
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Immunodijfusion studies
For the immunochemical characterization of reaction products from GBM digestion a rabbit anti-GBM serum was used. Gel diffusion analysis showed at least four precipitation lines in the final supernatant (Fig. 4) . Fraction 1 also yielded several lines but fraction 2 did not appear to possess antigenic properties.
Human leucocyte proteolytic activity (Table 2)
Assays with azocasein indicated considerable neutral protease activity in human polymorphonuclear leucocyte azurophil granules (21-4 units/10 9 leucocytes). This proteolytic activity comprised at least two distinct neutral proteases.
The activity against a low-molecular-weight sub strate for elastase was 3-5 units/10 9 leucocytes, and for cathepsin G was 8-1 units/10 9 leucocytes. In our experiments we failed to detect cathepsin B activity in polymorphonuclear leucocytes.
Effects of incubating purified cathepsin B with human GBM
Purified human cathepsin B released hydroxyproline into the medium upon incubation at 37°C and pH 4·0, as shown in Fig. 1(6) . Up to 90% of the total hydroxyproline was released over the 18 h incubation period, when the reaction mixture con tained 1-25 units of cathepsin B. When the same amount of elastase was used in the incubation mixture about 45% of hydroxyproline was released, and with cathepsin G about 5% (Fig la) . Incubating cathepsin D (EC 3.4.23.5) with GBM at pH 3-4 showed that GBM collagen was not solubilized by cathepsin D. . 
Discussion
Our results make it clear that human lysosomal elastase and cathepsin G have the ability to degrade human glomerular basement membrane (GBM) in vitro at neutral pH. The exact nature of the digestion products was not established, nor did we examine in detail the insoluble material left after digestion. However, since substantially all the hydroxyproline present in the GBM became soluble FIG. 3 . Electrophoresis in SDS-polyacrylamide gels of human GBM and of fraction 1 isolated by gel chromatography of the products from incubation with neutrophil cathepsin G.
over the incubation period the released products are tentatively identified as collagen or collagen-like proteins. This conclusion is supported by previous studies, which show that a highly specialized collagen (type IV) is present in basement mem brane (Kefalides, 1973) . Our results also imply that elastase and cathepsin G degrade the GBM in a similar manner. A number of proteolytic enzymes are capable of solubilizing basement-membrane collagen and studies by Rubin, Drake, Davison, Pfahl, Speakman & Schmitt (1965) , Drake, Davison, Bump & Schmitt (1966) , Kefalides (1969) and Chung, Rhodes & Miller (1976) suggest that these enzymes act by hydrolysing a non-collagen component present in the membrane. Elastase and cathepsin may act in a similar way. Recent studies have shown that both elastase and cathepsin G act on cartilage as well as GBM in a similar manner to bring about extensive release of proteoglycan and solubilization of collagen, and also that the residual collagen has become deg raded in some way (Barrett & Starkey, 1977) . The same workers also demonstrated that elastase and to a lesser degree cathepsin G degraded acidsoluble skin collagen. Thus in addition to the type IV collagen of GBM, leucocyte neutral proteinases degrade collagens of types I and II.
It is noteworthy that the protein(s) released by the neutral proteases in our experiments were excluded from Sephadex G-100, although upon acrylamide-gel electrophoresis in the presence of sodium dodecyl sulphate and mercaptoethanol they were resolved into several fractions well within the exclusion limits for this grade of Sephadex. These findings are consistent with other work in which products of GBM degradation have been isolated by gel chromatography. Thus Kefalides (1969) observed that limited digestion of GBM with pronase at 18°C resulted in the solubilization of a fraction that emerged as a single homogeneous peak on Sephadex G-100. Upon electrophoresis this peak resolved into several components resem bling interstitial collagen and smaller fragments of GBM collagen. Marquardt, Wilson & Dixon (1973a) showed that analysis of chaotropically solubilized basement-membrane proteins revealed three prominent bands and up to 19 other lessintense bands, with apparent molecular weights ranging from 28 000 to 94 000. Chung et al. (1976) have reported that after pepsin digestion of several human tissues a high-molecular-weight type IV collagen was released, which after reduction and rechromatography on the same column was recovered as collagen-like subunits with apparent molecular weight of 50 000.
Our immunochemical analysis of the solubilized membrane also demonstrated that digestion of GBM with elastase and cathepsin G released a complex mixture of proteins, at least four distinct precipitin lines being detected by rabbit anti-(human GBM) antiserum. Several reports have suggested that a number of major antigenic components are present in GBM (Kefalides, 1973; Marquardt et al., 1973a,b) . Studies to date have identified antigenic determinants in the collagen component as well as in low-and high-molecularweight glycoproteins of GBM.
Two main types of granules, azurophil and specific, have been identified morphologically and biochemically in human polymorphonuclear leucocytes (Bainton, Ullyot & Farquahar, 1971; Bretz & Baggiolini, 1974; Dewald, RindlerLudwig, Bretz & Baggiolini, 1975) . Elastase and cathepsin G are localized together with other lysosomal hydrolases in the azurophil granules (Dewald et al., 1975) . In contrast, neutral collagenase, the third major proteinase of human leucocyte, is exclusively found in the specific granules (Murphy, Reynolds, Bretz & Baggiolini, 1977) . This finding may explain the higher rate of release for elastase and cathepsin G and other hydrolases over that of coUagenase from phagocytosing polymorphonuclear leucocytes (Oransky, Perper & Schroder, 1973) . This raises the question of whether leucocyte coUagenase is involved in GBM breakdown. There are numerous reports which indicate that collagenases of bacterial origin digest and solubilize significant amounts of GBM (Spiro, 1967; Kefalides, 1973; Mathieu & Winand, 1973) , but so far there is no evidence to indicate that leucocyte coUagenase digests human GBM.
We found that cathepsin B was the most effective of the four tissue proteinases studied. Cathepsin B was not, however, detectable in human polymorphonuclear leucocytes, but this thiol-dependent enzyme is present in human kidney (M. Davies, unpublished results). In contrast, cathepsin D, a carboxyl proteinase also found in lysosomes, had no effect. These results are in agreement with reports which show that cathepsin B, but not cathepsin D, degrades native collagen at acid pH (Burleigh et al., 1974; Etherington, 1974) . At present it is uncertain what enzymes are responsible for the breakdown of GBM com ponents under normal conditions. From our results it would appear possible that kidney lysosomes through the action of cathepsin B may play a significant role.
The idea that neutral proteinases of leucocytes may induce damage to the GBM is supported by numerous studies that clearly show these enzymes are released when leucocytes come into contact with non-phagocytosable particles, such as immune complexes or aggregated IgG (for review see Ignarro, 1975) . In glomerulonephritis deposits of immunoglobulins and complement factors are found along the basement membrane of diseased glomeruli. Further, light-and electron-microscopy show that the polymorphonuclear leucocytes can accumulate in such glomeruli. Studies of renal biopsies both in experimental and human glomerulonephritis clearly indicate that the leucocytes gain intimate contact with the basement membrane by positioning themselves between this structure and the endothelial cells. Our degradation experiments were carried out with the neutral proteinase activity equivalent to 50 ml of whole blood. There are no definitive data on the leucocyte content of diseased kidneys, but our unpublished results would suggest that it is not unusual for more than five polymorphonuclear leucocytes to be present per glomerulus in thin tissue sections, in proliferative glomerulonephritis. Therefore the con centration of purified enzyme used in vitro would not seem excessive in vivo. We have found that the urine of patients with rapidly progressive glomerulonephritis contains both an increased amount of GBM fragments, and also a neutral proteinase having many of the properties of leucocyte elastase (Sanders et al., 1976) . There is thus a great deal of evidence indicating that our results obtained in vitro with leucocyte neutral proteases are directly relevant to the pathological process of GBM degradation by leucocytes in vivo.
